<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Broome DT</submitter><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><pagination>237-250</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7765647</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>106(1)</volume><pubmed_abstract>Maturity-onset diabetes of the young, or MODY-monogenic diabetes, is a not-so-rare collection of inherited disorders of non-autoimmune diabetes mellitus that remains insufficiently diagnosed despite increasing awareness. These cases are important to efficiently and accurately diagnose, given the clinical implications of syndromic features, cost-effective treatment regimen, and the potential impact on multiple family members. Proper recognition of the clinical manifestations, family history, and cost-effective lab and genetic testing provide the diagnosis. All patients must undergo a thorough history, physical examination, multigenerational family history, lab evaluation (glycated hemoglobin A1c [HbA1c], glutamic acid decarboxylase antibodies [GADA], islet antigen 2 antibodies [IA-2A], and </pubmed_abstract><journal>The Journal of clinical endocrinology and metabolism</journal><pubmed_title>Approach to the Patient with MODY-Monogenic Diabetes.</pubmed_title><pmcid>PMC7765647</pmcid><funding_grant_id>R01DK104942</funding_grant_id><funding_grant_id>P30 DK020595</funding_grant_id><funding_grant_id>R01 DK104942</funding_grant_id><funding_grant_id>P30DK020595</funding_grant_id><funding_grant_id>U54 DK118612</funding_grant_id><funding_grant_id>DK118612-01</funding_grant_id><pubmed_authors>Kashyap SR</pubmed_authors><pubmed_authors>Philipson LH</pubmed_authors><pubmed_authors>Pantalone KM</pubmed_authors><pubmed_authors>Broome DT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Approach to the Patient with MODY-Monogenic Diabetes.</name><description>Maturity-onset diabetes of the young, or MODY-monogenic diabetes, is a not-so-rare collection of inherited disorders of non-autoimmune diabetes mellitus that remains insufficiently diagnosed despite increasing awareness. These cases are important to efficiently and accurately diagnose, given the clinical implications of syndromic features, cost-effective treatment regimen, and the potential impact on multiple family members. Proper recognition of the clinical manifestations, family history, and cost-effective lab and genetic testing provide the diagnosis. All patients must undergo a thorough history, physical examination, multigenerational family history, lab evaluation (glycated hemoglobin A1c [HbA1c], glutamic acid decarboxylase antibodies [GADA], islet antigen 2 antibodies [IA-2A], and </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-04T03:40:13.128Z</modification><creation>2022-02-11T11:59:56.005Z</creation></dates><accession>S-EPMC7765647</accession><cross_references><pubmed>33034350</pubmed><doi>10.1210/clinem/dgaa710</doi></cross_references></HashMap>